Immunologic Effects of CDX-301 and CDX-1140 in Resectable Pancreatic Cancer Patients
Clinical trial NCT04536077 · TERMINATED
Trial details
- NCT number
- NCT04536077
- Sponsor
- Washington University School of Medicine
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-13
- Primary completion
- 2023-11-21
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.